Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2006

Jun 21, 2006

30718_dirs_2006-06-21_3aa4b28d-7c0d-456d-ab68-f76d2de98cf5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (tech)
CIK: 0000842023
Period of Report: 2006-06-19

Reporting Person: VERONNEAU MARCEL (VP - Hematology Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-06-19 Common Stock M 1498 $12.6875 Acquired 30444 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-06-19 Employee stock option $12.6875 M 1498 Disposed 2006-06-30 Common stock (1498) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common stock 6140 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee stock option $65 2007-06-30 Common stock (338) 338 Direct
Employee stock option $32.5 2008-06-30 Common stock (748) 748 Direct
Employee stock option $28.22 2009-06-30 Common stock (785) 785 Direct
Employee stock option $33.85 2010-08-13 Common stock (670) 670 Direct
Employee stock option $37.011 2010-11-30 Common stock (15000) 15000 Direct
Employee stock option $40.47 2011-07-08 Common stock (505) 505 Direct
Employee stock option $51.6 2012-08-17 Common stock (475) 475 Direct

Footnotes

F1: Exercisable 5,000 each on 12/1/03; 12/1/04; and 12/1/05